3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Lung Neoplasms
15
Carcinoma, Non-Small-Cell Lung
9
Thymoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Pneumonia
1
Pleural Effusion, Malignant
1
Pleural Diseases
1
Pain, Postoperative
1
Pain
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Primary Lung Cancer
1
Mesothelioma, Malignant
1
Lung Injury
1
Liver Neoplasms
1
Leiomyoma
1
Hypoxia
1
Hemorrhage
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Interventions
Cisplatin
28
Pemetrexed
24
pembrolizumab
12
Nivolumab
10
Carboplatin
9
atezolizumab
7
Gemcitabine
7
Cyclophosphamide
7
durvalumab
6
Drug Therapy
6
sodium thiosulfate
5
Radiotherapy, Intensity-Modulated
5
tremelimumab
4
aldesleukin
4
Radiotherapy
4
Interleukin-2
4
sargramostim
3
Vinorelbine
3
Platinum
3
Photochemotherapy
3
Ipilimumab
3
Doxorubicin
3
Dihematoporphyrin Ether
3
Chemotherapy, Adjuvant
3
Cerebral Decortication
3
vatalanib
2
regorafenib
2
niraparib
2
lenvatinib
2
cemiplimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Mesothelioma, Malignant
×
Thoracic Surgery, Video-Assisted
×
Clear all
NCT04400539
2025-09-25
IMPALA
University Hospital, Lille
Phase 2
Recruiting
20 enrolled